(주)셀렉스라이프사이언스

News

ILIAS is the Leader of Next-Generation Exosome Therapeutics.

[ENG] 보도자료

ILIAS's new publication provides an overview of the recent advances and highlights in exosome-based therapeutics

페이지 정보

  • 작성자 : ILIAS Biologics
  • 작성일 : 20-09-04 13:26
  • 조회 : 220회

본문


26 Aug 2020


ILIAS's new publication provides an overview of the recent advances and highlights in exosome-based therapeutics

 

Our scientists at ILIAS Biologics Inc. have recently published a review article in a peer-reviewed medical journal, the American Journal of Reproductive Immunology (AJRI).

This publication provides an overview of the recent advances in exosome research and highlights the challenges in bringing the exosome-based therapeutics from bench to bedside.

Various exosome engineering technologies, including ILIAS’s EXPLOR® (EXosome engineering for Protein Loading via Optically Reversible protein-protein interactions), are also compared in the article. 

To learn more about the paper, visit Journal Website.

(Click) “The emerging role of exosomes as novel therapeutics: biology, technologies, clinical applications, and the next.” AJRI, 2020. 

개인정보취급방침

닫기

이메일주소무단수집거부

닫기

사이트맵

사이트맵

몬트리올의정서
국내이행법령
사업안내
특정물질 수출입
알림·자료실
민원서비스
닫기